|
| 36427857 | Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B. | Aliment Pharmacol Ther | 2023 |
| 36519892 | Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection. | Antimicrob Agents Chemother | 2023 |
| 34279652 | Transcriptomic Analysis of Livers of Inactive Carriers of Hepatitis B Virus With Distinct Expression of Hepatitis B Surface Antigen. | J Infect Dis | 2022 |
| 35581938 | Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo. | Mol Ther | 2022 |
| 35363817 | Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy. | PLoS One | 2022 |
| 36477212 | Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virus. | PLoS One | 2022 |
| 36908748 | Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells. | JHEP Rep | 2022 |
| 36037476 | Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System. | J Virol | 2022 |
| 35977609 | Reply to: "Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection". | J Hepatol | 2022 |
| 35218813 | Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection. | J Hepatol | 2022 |
| 35295767 | Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B. | JHEP Rep | 2022 |
| 32894807 | Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance. | J Viral Hepat | 2021 |
| 33657432 | Generation of an HBV core phenotyping assay for evaluating HBV capsid compounds. | J Virol Methods | 2021 |
| 34950863 | Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection. | JHEP Rep | 2021 |
| 34287049 | Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines. | J Virol | 2021 |
| 33148795 | Characterization of Hepatitis B Precore/Core-Related Antigens. | J Virol | 2021 |
| 32780526 | Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase. | Hepatology | 2021 |
| 32609910 | Developing a sensitive HBV genotyping assay for HBV DNA suppressed patients using both DNA and RNA sequencing. | J Med Virol | 2020 |
| 27872061 | Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients. | Antimicrob Agents Chemother | 2017 |
| 26055360 | Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults. | Antimicrob Agents Chemother | 2015 |
| 24492299 | In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation. | MAbs | 2014 |
| 24843144 | Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109. | Proc Natl Acad Sci U S A | 2014 |
| 24722349 | A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection. | PLoS Pathog | 2014 |
| 23562482 | Characterization of the guinea pig CMV gH/gL/GP129/GP131/GP133 complex in infection and spread. | Virology | 2013 |
| 22532696 | Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin. | J Virol | 2012 |
| 17459934 | In vitro analysis of transneuronal spread of an alphaherpesvirus infection in peripheral nervous system neurons. | J Virol | 2007 |
| 17764949 | Actin and Rho GTPases in herpesvirus biology. | Trends Microbiol | 2007 |
| 17686845 | Pseudorabies virus Us9 directs axonal sorting of viral capsids. | J Virol | 2007 |
| 16933992 | Alpha-herpesvirus infection induces the formation of nuclear actin filaments. | PLoS Pathog | 2006 |
| 16355535 | Regulation of actin assembly by microtubules in fission yeast cell polarity. | Novartis Found Symp | 2005 |
| 14681407 | The Gene Ontology (GO) database and informatics resource. | Nucleic Acids Res | 2004 |
| 15184402 | Regulation of a formin complex by the microtubule plus end protein tea1p. | J Cell Biol | 2004 |
| 15153302 | Saccharomyces genome database: underlying principles and organisation. | Brief Bioinform | 2004 |
| 14681421 | Saccharomyces Genome Database (SGD) provides tools to identify and analyze sequences from Saccharomyces cerevisiae and related sequences from other organisms. | Nucleic Acids Res | 2004 |
| 11731324 | Cytokinesis and the contractile ring in fission yeast. | Curr Opin Microbiol | 2001 |
| 11696322 | Roles of the fission yeast formin for3p in cell polarity, actin cable formation and symmetric cell division. | Curr Biol | 2001 |
| 9885248 | Alf1p, a CLIP-170 domain-containing protein, is functionally and physically associated with alpha-tubulin. | J Cell Biol | 1999 |
| 9520439 | Parallel analysis of genetic selections using whole genome oligonucleotide arrays. | Proc Natl Acad Sci U S A | 1998 |
| 9265649 | Tubulin subunits exist in an activated conformational state generated and maintained by protein cofactors. | J Cell Biol | 1997 |